Apotex Pharmachem India Profile
Key Indicators
- Authorised Capital ₹ 100.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 76.31 Cr
as on 23-10-2024
- Company Age 21 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 137.20 Cr
as on 23-10-2024
- Revenue -3.58%
(FY 2023)
- Profit 26.36%
(FY 2023)
- Ebitda 10.94%
(FY 2023)
- Net Worth 3.09%
(FY 2023)
- Total Assets 2.40%
(FY 2023)
About Apotex Pharmachem India
The Corporate was formerly known as Brantford Chemicals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 100.00 Cr and a paid-up capital of Rs 76.31 Cr.
The company has closed loans amounting to ₹137.20 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Apotex Pharmachem India Private Limited India is Renu Sharma as COMPANY SECRETARY. Yoganjaneya Panem, Brian Mcclelland, and Kajal Palan serve as directors at the Company.
- CIN/LLPIN
U24231KA2003PTC032104
- Company No.
032104
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jun 2003
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- LocationBangalore, Karnataka
- Telephone
- Email Address
- Website
- Social Media
What products or services does Apotex Pharmachem India Private Limited offer?
Apotex Pharmachem India Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API.
Who are the key members and board of directors at Apotex Pharmachem India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Renu Sharma | Company Secretary | 23-Mar-2024 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yoganjaneya Panem  | Director | 09-Jun-2015 | Current |
Brian Mcclelland  | Director | 06-May-2024 | Current |
| Kajal Palan | Additional Director | 03-May-2024 | Current |
Financial Performance and Corporate Structure Insights of Apotex Pharmachem India.
Apotex Pharmachem India Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.58% decrease. The company also saw a substantial improvement in profitability, with a 26.36% increase in profit. The company's net worth moved up by a moderate rise of 3.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apotex Pharmachem India?
In 2023, Apotex Pharmachem India had a promoter holding of 99.93% and a public holding of 0.07%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Apotex Research Private Limited
Active 21 years 4 monthsYoganjaneya Panem, Brian Mcclelland and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 21 Jul 2016 | ₹6.00 M | Satisfied |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 24 Apr 2014 | ₹19.80 Cr | Satisfied |
The Hongkong And Shanghai Banking Corporation Ltd Creation Date: 27 Sep 2013 | ₹19.80 Cr | Satisfied |
How Many Employees Work at Apotex Pharmachem India?
Apotex Pharmachem India has a workforce of 209 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apotex Pharmachem India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apotex Pharmachem India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
